PANOBINOSTAT for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where PANOBINOSTAT was used for Prostate cancer.
Most Reported Side Effects for PANOBINOSTAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 368 | 20.2% | 76 | 124 |
| Plasma cell myeloma | 279 | 15.3% | 170 | 80 |
| Platelet count decreased | 192 | 10.6% | 72 | 90 |
| Death | 190 | 10.4% | 189 | 17 |
| Malignant neoplasm progression | 166 | 9.1% | 104 | 61 |
| Fatigue | 162 | 8.9% | 28 | 46 |
| Nausea | 154 | 8.5% | 44 | 63 |
| Thrombocytopenia | 141 | 7.8% | 30 | 60 |
| Off label use | 112 | 6.2% | 37 | 9 |
| Vomiting | 109 | 6.0% | 20 | 60 |
| Drug ineffective | 105 | 5.8% | 46 | 18 |
| Pneumonia | 99 | 5.4% | 39 | 69 |
| Pyrexia | 98 | 5.4% | 40 | 65 |
| Anaemia | 95 | 5.2% | 39 | 49 |
| White blood cell count decreased | 83 | 4.6% | 35 | 49 |
Other Indications for PANOBINOSTAT
Plasma cell myeloma (1,262)
Product used for unknown indication (244)
Plasma cell myeloma refractory (49)
Acute myeloid leukaemia (33)
Brain stem glioma (15)
Plasmacytoma (14)
Hodgkin's disease (13)
Plasma cell leukaemia (12)
Glioma (10)
Graft versus host disease (10)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)